Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Vitamin Shoppe Falls as Acquisition Hurts Profit

Feb. 26 (Bloomberg) -- Vitamin Shoppe Inc. fell the most since its 2009 market debut after the supplements retailer reported fourth-quarter profit that trailed analysts’ estimates and said a recent acquisition will hurt earnings this year.

The shares tumbled 19 percent to $51.44 at the close in New York, for the biggest one-day drop since October 2009. The North Bergen, New Jersey-based company had gained 10 percent this year through yesterday, while the Standard & Poor’s Smallcap 600 Index advanced 5.2 percent.

Vitamin Shoppe, with more than 580 company-operated stores, said today in a statement that transaction and integration costs related to the $50 million acquisition of Seattle-based retailer Super Supplements Inc., which closed this month, will reduce profit by 3 cents a share this year.

Fourth-quarter profit rose 2.8 percent to $9.68 million, or 32 cents a share, from $9.41 million, or 32 cents, a year earlier. The average of 14 analysts’ estimates compiled by Bloomberg was 40 cents. Sales advanced 1.9 percent to $218.9 million. Analysts estimated $223.8 million, on average.

Results in the quarter included 8 cents a share in costs related to Hurricane Sandy, startup costs in Canada and the Super Supplements takeover.

To contact the reporter on this story: Niamh Ring in New York at

To contact the editor responsible for this story: Kevin Miller at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.